Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name RBM5-AS1
   Synonyms RBM5-AS1, LUST
   Region GRCh38_3:50099603-50100988    Sequence
   Ensembl ENSG00000281691
   RefSeq NR_045388
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colon cancer
   ICD-0-3 C18  
   Methods qPCR, Cell transfection, Dual-luciferase reporter assay, Flow cytometry assay etc.
   Sample cell lines (LS174T, SW480, HT-29, CaCo-2, DLD-1 and HCT 116)
   Expression Pattern differential expression
   Function Description

In this study, we report enrichment of the lncRNA RBM5-AS1/LUST during sphere formation of colon CIC. Its silencing impaired WNT signaling, whereas its overexpression enforced WNT signaling, cell growth, and survival in serum-free media. Mechanistic investigations showed that silencing or overexpression of RBM5-AS1 caused a respective loss or retention of B-catenin from TCF4 complexes bound to the WNT target genes SGK1, YAP1, and MYC Our work suggests that RBM5-AS1 activity is critical for the functional enablement of colon cancer stem-like cells. Furthermore, it defines the mechanism of action of RBM5-AS1 in the WNT pathway via physical interactions with B-catenin, helping organize transcriptional complexes that sustain colon CIC function.

   Pubmed ID 27520449
   Year 2016
   Title RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.
   External Links
   Links for  RBM5-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  colon cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.